Literature DB >> 17182004

The induction mechanism of the molecular chaperone HSP70 in the gastric mucosa by Geranylgeranylacetone (HSP-inducer).

Michiro Otaka1, Soh Yamamoto, Kaori Ogasawara, Yuka Takaoka, Susumu Noguchi, Toshio Miyazaki, Akira Nakai, Masaru Odashima, Tamotsu Matsuhashi, Sumio Watanabe, Hideaki Itoh.   

Abstract

To elucidate the induction mechanism of HSP70 by geranylgeranylacetone (GGA), we investigated GGA specific binding proteins using a GGA-affinity column. Alteration of chaperone activity of HSP70 and binding affinity of HSP70 to heat shock factor-1 (HSF-1) was evaluated in the presence or absence of GGA. The binding domain of HSP70 to GGA was also analyzed. A 70-kDa protein eluted by 10 mM GGA from the GGA-affinity column was identical to constitutively expressed HSP70 on immunoblotting. GGA-binding domain of HSP70 was C-terminal of the protein as peptide-binding domain (HSP70C). The chaperone activity of HSP70 and recombinant HSP70C was suppressed by GGA. Furthermore, dissociation of the HSP70 from HSF-1 was observed in the presence of GGA. GGA preferentially binds to the C-terminal of HSP70 which binds to HSF-1. After dissociation of HSP70, free HSF-1 could acquire the ability to bind to HSE (the promoter region of HSP70) gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182004     DOI: 10.1016/j.bbrc.2006.12.031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 2.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

3.  Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.

Authors:  Aikaterini Rousaki; Yoshinari Miyata; Umesh K Jinwal; Chad A Dickey; Jason E Gestwicki; Erik R P Zuiderweg
Journal:  J Mol Biol       Date:  2011-06-25       Impact factor: 5.469

4.  Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma.

Authors:  Hiroshi Kubota; Soh Yamamoto; Eri Itoh; Yuki Abe; Asami Nakamura; Yukina Izumi; Hirotaka Okada; Masatake Iida; Hiroshi Nanjo; Hideaki Itoh; Yuzo Yamamoto
Journal:  Cell Stress Chaperones       Date:  2010-07-09       Impact factor: 3.667

Review 5.  Targeting Hsp70: A possible therapy for cancer.

Authors:  Sanjay Kumar; James Stokes; Udai P Singh; Karyn Scissum Gunn; Arbind Acharya; Upender Manne; Manoj Mishra
Journal:  Cancer Lett       Date:  2016-02-17       Impact factor: 8.679

Review 6.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 7.  Pharmacological targeting of the Hsp70 chaperone.

Authors:  Srikanth Patury; Yoshinari Miyata; Jason E Gestwicki
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

8.  Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones.

Authors:  Nobuhiro Fujikake; Yoshitaka Nagai; H Akiko Popiel; Yuma Okamoto; Masamitsu Yamaguchi; Tatsushi Toda
Journal:  J Biol Chem       Date:  2008-07-16       Impact factor: 5.157

9.  Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy.

Authors:  Atsushi Sanbe; Takuya Daicho; Reiko Mizutani; Toshiya Endo; Noriko Miyauchi; Junji Yamauchi; Kouichi Tanonaka; Charles Glabe; Akito Tanoue
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model.

Authors:  Takayoshi Fujibayashi; Naozumi Hashimoto; Mayumi Jijiwa; Yoshinori Hasegawa; Toshihisa Kojima; Naoki Ishiguro
Journal:  BMC Pulm Med       Date:  2009-09-16       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.